Caricamento...
MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
BACKGROUND: Cisplatin (DDP)-based chemotherapy is the mainstay of first-line therapy for lung cancer. However, their efficacy is often limited by the existence or development of chemoresistance. The aim of this study was to find and investigate the function of miRNAs in cisplatin (DDP)-resistant non...
Salvato in:
| Pubblicato in: | Cancer Cell Int |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4828824/ https://ncbi.nlm.nih.gov/pubmed/27073334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-016-0305-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|